PDIA3 and nonpapillary renal cell carcinoma: In fact, we found that after knocking down AURKC in ccRCC or following treatment with a phosphokinase inhibitor, the expression level of ERp57 was significantly downregulated, and the distribution of ERp57 in the nucleus also decreased, providing evidence in support of our hypothesis.